Browsing: startup

Vesalic targets ‘toxic exosome’ identified in ALS patients, suggesting disease biology may not be confined to the brain and CNS.…

Luffu targets collective health and wellbeing across families by tracking changes to normal ‘rhythms’ over time. With the longevity conversation…

Neurotech company targets non-surgical methods for connecting humans with ‘advanced AI’ and other technologies.   Sam Altman’s latest venture, brain-computer…

TECregen lands seed funding for mission to combat age-related immune decline by regenerating thymic epithelial cells. Swiss biotech TECregen emerged…

Liom boasts miniaturization breakthrough in spectroscopy-powered continuous glucose monitoring technology.   Swiss healthtech startup Liom has secured a $16.5 million…

Devin Partida on the fine line between longevity wellness and regulated healthcare – and why product design decisions matter early.…

OpenAI-backed Chai Discovery lands $130m, claiming “100-fold improvement” over previous computational design methods. AI-native drug discovery platform Chai Discovery has…

Subsense secures additional $10m following progress towards nanoparticle-based approach to neural interface control. Neurotech startup Subsense has expanded its total…

General Control enters Novo Nordisk’s Co-Creation Greenhouse to advance multiplex epigenetic editing for complex chronic disease. General Control, a previously…

BASE4 Biosciences focuses exclusively on female biological data to address women’s underrepresentation in biomedical research. Women’s health biotech BASE4 Biosciences…